Outlook Therapeutics is trading 8.13% up at $0.67, supported by broader market strength despite no newly identified company-specific announcement on August 27, 2026.
- Latest company releases remain its August 14 financial update and August 12 financing announcement, both previously established developments.
- The Nasdaq Composite is up 0.70%, with strong technology earnings benefiting growth-stock sentiment; no direct catalyst has been confirmed.